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Abstract
Background: Ether-a `-go-go (EAG) channels are expressed throughout the central nervous system and are also crucial
regulators of cell cycle and tumor progression. The large intracellular amino- and carboxy- terminal domains of EAG1 each
share similarity with known ligand binding motifs in other proteins, yet EAG1 channels have no known regulatory ligands.
Methodology/Principal Findings: Here we screened a library of small biologically relevant molecules against EAG1 channels
with a novel two-pronged screen to identify channel regulators. In one arm of the screen we used electrophysiology to
assess the functional effects of the library compounds on full-length EAG1 channels. In an orthogonal arm, we used
tryptophan fluorescence to screen for binding of the library compounds to the isolated C-terminal region.
Conclusions/Significance: Several compounds from the flavonoid, indole and benzofuran chemical families emerged as
binding partners and/or regulators of EAG1 channels. The two-prong screen can aid ligand and drug discovery for ligand-
binding domains of other ion channels.
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Introduction
The EAG family of voltage-gated K
+ channels is encoded by
genes KCNH1-8 [1]. EAG family channels cluster by sequence
similarity into three subfamilies: ether-a `-go-go (EAG), eag-related
gene (ERG) and eag-like K
+ channel (ELK) [2]. For the most part,
EAG1 expression is confined to the central nervous system [3].
However, EAG1 mRNA is also expressed in several cell lines
derived from canceroustumorsandinmosttypesofhumanprimary
cancer studied so far [4,5,6,7,8]. Cells exogenously expressing
EAG1 channels display properties seen in cancerous cells, including
aggressive tumor formation when injected into immune-depressed
mice [8]. Further, pharmacologic blockade of EAG1 channel
activity [9,10,11] and inhibition of channel expression by RNAi
interference [12] decreased cell proliferation in tumor tissues.
Channels in the EAG family share a basic architecture with most
voltage-gated K
+ channels. They have four subunits arranged to
form a central, K
+ conducting pore (Fig. 1A). In addition, each
subunithas large intracellular amino- andcarboxy-terminalregions.
The amino-terminal region contains a Per-Arnt-Sim (PAS) domain
[13]. In other proteins, PAS domains serve as signaling modules that
bind to small molecules and other proteins [14]. The carboxy-
terminal region contains a cyclic nucleotide-binding domain
(CNBD) that shares sequence similarity with the CNBD of the
cyclic nucleotide-gated (CNG) channels, and hyperpolarization-
activated cyclic nucleotide-modulated (HCN) channels (Fig. 1A)
[2,15].DespitehavingaCNBD,vertebrateEAGfamilychannelsare
not regulated by the direct binding of cyclic nucleotides [16,17].
Because they contain known binding motifs but no known ligands,
we classify EAG1 channels as orphan receptors.
We sought to deorphanize the EAG1 channel by identifying
compounds that regulate the channel and bind to the CNBD. In
this study we developed a novel, two-pronged approach to screen a
chemical library for EAG1 channel regulators. The compounds in
the library were simultaneously screened for functional effects on
the EAG1 channels using inside-out patch-clamp recordings, and
for binding to the CNBD using tryptophan fluorescence. The
combined use of two orthogonal screens greatly increases the
chances of identifying a specific channel regulator. With this two-
pronged screen we uncovered several regulators and binding
partners for EAG1 channels that cluster into three distinct
chemical families: flavonoids, indoles, and benzofurans.
Results
ToidentifyEAG1channelregulators,wescreenedaversionofthe
Fragments of Life (FOL) chemical library (Emerald BioStructures,
Bainbridge Island, WA) against EAG1 channels with electrophys-
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consists of 218 metabolites, and derivatives thereof, involved in
diverse metabolic pathways and produced by various living
organisms. The FOL library used in our study contained 768 small
biologically relevant molecules grouped into 96 pools of seven to ten
compounds. The distribution of the library compounds into pools
allowed for a more efficient method of library screening. The FOL
library was created based on knowledge of protein structures and
their cognate metabolite-binding partners for structure-based drug
discovery, and was previously used to identify modulators of
leukotriene A4 hydrolase [18]. Here we implemented a novel
applicationoftheFOL libraryasa screen for EAG1channel ligands.
Screening the FOL library with electrophysiology
To screen for functional effects on the full length EAG1
channels, pools of the FOL compounds were applied to membrane
Figure 1. Schematic of the two-pronged screen designed to identify compounds that bind and regulate EAG1 channels. (A) EAG1
channel subunits form tetramers around a central, K
+ conducting pore. The ribbon representation is a homology model of mEAG1#505-702,
obtained with SWISS-MODEL based on the crystal structure of the carboxy-terminal region of mHCN2 [42]. Enlarged view on the right shows a
tryptophan residue at position 649 in the CNBD employed as a reporter of ligand binding. (B) For the electrophysiology arm of the screen, mEAG1
channels were expressed heterologously and the FOL pools were applied to inside-out patches containing these channels. The currents from EAG1
channels were recorded in the absence (black), presence (red) and after washout of FOL compounds. The conductance-voltage relationship was
determined from the tail currents and normalized to the maximal conductance in the absence of drug. (C) For the fluorescence portion of the screen,
mEAG1#505-702 was expressed and purified from bacteria. The FOL compounds were applied to mEAG1#505-702 in solution, the sample was
placed in a quartz cuvette and excited at 280 nm wavelength. The mEAG1#505-702 emission spectra were recorded in the absence and presence of
the FOL compounds (black and red traces, respectively).
doi:10.1371/journal.pone.0012523.g001
Identifying EAG1 Regulators
PLoS ONE | www.plosone.org 2 September 2010 | Volume 5 | Issue 9 | e12523patches expressing EAG1 channels. The EAG1 currents were
recorded in the inside-out configuration of the patch-clamp
technique in order to expose the intracellular putative ligand
binding domains to the library compounds. Currents were
recorded in response to depolarizing voltage steps in the absence,
presence, and after washout of FOL compounds (Fig. 1B, see
Materials and Methods). The currents were then analyzed to
determine the effects of the FOL compounds on the conductance-
voltage relationship, and the kinetics of activation and deactiva-
tion. In the first round of screening, we tested 96 pools each
containing seven to ten FOL compounds. Pools that were
identified as ‘hits’ were further studied by examining the effects
of their individual compounds on channel gating.
Screening the FOL library with tryptophan fluorescence
In parallel with the electrophysiology screen, binding of the
FOL compounds to the isolated C-terminal region of EAG1
channels containing both the C-linker and CNBD, mEAG1#505-
702, was probed with a fluorescence based screen. This screen
employs tryptophan fluorescence, which is environmentally
sensitive and hence can be used to report ligand binding [19].
For example, the fluorescence intensity of a tryptophan residue
introduced in the cyclic nucleotide-binding pocket of the HCN2
channel at position 586, decreased upon binding of cyclic-
nucleotides in a concentration dependent manner [16]. The
mEAG1#505-702 has two endogenous tryptophan residues: at
position 649, analogous to 586 in HCN2 channels (enlarged view
in Fig. 1A), and at position 544 in the C-linker. The fluorescence
of these tryptophan residues could change upon ligand binding to
the isolated C-terminal region of EAG1 channel, as observed in
HCN2 channels with cyclic nucleotides. The data acquisition
procedure is summarized in Fig. 1 and is described in more detail
in Fig. S1. In each experiment, the fluorescence emission spectra
of mEAG1#505-702 were recorded in a quartz cuvette before and
after addition of the FOL pools (Fig. 1C and Fig. S1A). Some
pools were themselves fluorescent upon excitation and/or had
high optical density leading to an inner filter effect. To separate
the background fluorescence of the pool from changes in the
tryptophan fluorescence, the emission spectra of the pool alone
was recorded (blue trace in Fig. S1A) and subtracted from that of
mEAG1#505-702 recorded in the presence of the pool. The
absorbance of each FOL pool was also recorded (Fig. S1B) and the
inner filter effect was corrected for as described in the
METHODS. The final emission spectra of mEAG1#505-702 in
the presence of a FOL pool represented the inner filter corrected
and background subtracted spectra (Fig. 1C and Fig. S1C).
Changes in tryptophan fluorescence intensity can result from
changes in the environment of the tryptophan residue or energy
transfer due to ligand binding. However changes in tryptophan
fluorescence may also arise from non-specific interactions between
the FOL compounds and free tryptophan in solution. To
determine the non-specific effects the pools of FOL compounds
were added to free tryptophan in solution. The fluorescence
spectrum of the free tryptophan was recorded before and after
addition of the FOL pools (Fig. S1A). Similar to the analysis for
mEAG1#505-702, the free tryptophan fluorescence was back-
ground subtracted and corrected for the inner filter effect (Fig.
S1A–C). The final effect of a compound was quantified as the
difference in the percent fluorescence intensity change of
mEAG1#505-702 and free tryptophan upon application of the
pool of FOL compounds and is referred to here as the relative
percent change (RPC). The pools of FOL compounds with high
RPC were further studied by examining individual compounds
separately.
Overview of the screen results
In the first round of the electrophysiology screen, we applied 96
pools of seven to ten FOL compounds to inside-out patches at a
concentration of 50 mM. The results from the electrophysiology-
based screen are summarized in heat maps in figures 2A–B.
Repeated application of four of the pools destroyed the membrane
seals, and these pools were removed from further analysis
(Figure 2A–B, grey boxes). The majority of the remaining FOL
pools reduced the maximal conductance of EAG1-expressing
patches (Figure 2A), and most of this conductance was recovered
with washout.Specifically,outof92pools-analyzed,onlytwo had no
effect on the maximal conductance, 60 pools reduced the maximal
conductance by 16–40% and 30 reduced the maximal conductance
by .40%. 32 of the pools shifted the Vhalf of the conductance versus
voltageplotby21to215 mV,19poolsdidnotevokeashift,and41
shifted the relationship to more positive potentials.
We sought to identify regulators that increased the open
probability of the channel. As an initial screen for such channel
regulators, the following criteria were used to identify ‘hit’ pools: 1)
they facilitated channel opening by shifting the conductance versus
voltage relationship to more negative potentials without evoking
substantial channel block, 2) they slowed the deactivation time
constant, and 3) the effects reversed with washout. To speed
analysis, channel kinetics were analyzed only for pools that shifted
the conductance versus voltage relationship to more negative
potentials. Open channel blockers can elicit hyperpolarizing shifts
in the conductance-voltage relationship and slowing of the
deactivation time constant in proportion to the amount of block.
Pools that evoked open channel block were excluded as hits. Using
these criteria, five pools were identified as ‘hits’ in the
electrophysiology portion of the screen. These five pools were
separated into their individual components, and four compounds
emerged as channel regulators. In addition, the fluorescence-based
binding assay was performed on each of the hits from the
electrophysiology portion of the screen.
In the first round of the fluorescence-based screen, pools of the
FOL compounds, with each compound at 100 mM concentration,
were applied to 4 mM Meag#505-702. Out of the 96 pools
examined, twenty nine showed dramatically high fluorescence
intensity and/or absorbance, precluding accurate measurement of
the Meag#505-702 fluorescence in the presence of these com-
pounds. The effect of these compounds on the fluorescence of
mEAG1#505-702 was analyzed at 2- to 100-fold lower concentra-
tions. Pools that had a larger effect on the fluorescence of free
tryptophan in solution compared to the effect on the fluorescence of
mEAG1#505-702 were removed from further analysis (Fig. 2C,
grey boxes). The remaining pools were categorized based on their
RPC. The results of the fluorescence based screen are summarized
in Fig. 2C where the RPC of the 96 pools is plotted in a green to
black color gradient with pools that had no effect on the
fluorescence of the protein colored in black. Fifteen pools with a
RPC of 10% or higher were identified as ‘hits’ and the individual
compounds of these pools were examined. RPC of a pool represents
a summationofRPCofindividualcompoundsinthe pool,therefore
individual compound in the pool might have RPC lower than the
total RPC of the pool. Out of the fifteen pools, seven contained
individual compounds with RPC,10% and the remaining eight
pools contained ten individual FOL compounds with RPC$10%.
The functional effects of these ten individual FOL compounds were
also tested using electrophysiology.
As a result of this two-pronged screen several compounds emerged
as binding partners and/or regulators of EAG1 channels (the
chemical structures of the compounds are shown in Fig. 3). Two FOL
compounds, luteolin and myricetin, were identified as regulators of
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of the screen. 5-chloroindole was identified as a ‘hit’ with the
electrophysiology screen, but showed no relative percent change in
the tryptophan fluorescence. This suggests that 5-chloroindole may
not bind to the CNBD to alter channel gating. Conversely, the
benzofurans 2-(6-methoxy-1-benzofuran-3-yl) acetic acid and benzo-
furan-2 carboxylic acid decreased the fluorescence intensity of
mEAG1#505-702, but had either no effect on EAG1 channel
gating or simply blocked the currents indicating that the binding of
these ligands does not regulate EAG1 channels. We focused our
attention on the two common hits identified by the combined screen
and three non-common hits that showed the largest effects.
Luteolin and myricetin bound to the CNBD region and
modulated gating of EAG1 channels
Luteolin and myricetin, both flavonoids, were identified
as binding partners and modulators of EAG1 channels. Both
Figure 2. Summary of the screen results. (A) The change in relative conductance of the electrophysiology portion of the screen is plotted in a
black to green color gradient, with pools that did not change the relative conductance colored black, and those with a 100% reduction in
conductance colored in bright green. (B) The shift of the Vhalf of the conductance versus voltage relationship from the electrophysiology portion of
the screen is plotted in a black to green color gradient, for shifts to more positive potentials indicated by shades of green (with a shift of 16 mV
indicated by the brightest green). Shifts of the conductance versus voltage relationship to more negative potentials are plotted in a black to red
gradient, with the brightest red indicating a shift of 216 mV. The pools that repeatedly destroyed membrane seals and were removed from further
analysis are indicated by grey boxes. (C) Results of the fluorescence based portion of the screen presented as RPC for each of the 96 FOL pools
plotted in a black to green color gradient with pools that had no effect on the tryptophan colored in black, and largest effects colored in bright
green. Grey boxes indicate the pools that had a larger effect on free tryptophan fluorescence than the fluorescence of the protein.
doi:10.1371/journal.pone.0012523.g002
Identifying EAG1 Regulators
PLoS ONE | www.plosone.org 4 September 2010 | Volume 5 | Issue 9 | e12523compounds had similar effects on the channel: they facilitated
channelopeningatmorenegative potentialsand sloweddeactivation
in a concentration-dependent manner (Fig. 4A and Fig. S2A).
30 mM luteolin shifted conductance/voltage relationship by an
average of 21560.9 mV, N=4, and increased deactivation time
constant at 2120 mV by 2.5 –fold from an average of 3.360.4 ms
before, to an average of 8.361.9 with luteolin, N=4 (Figs. 4B–C).
Plots of the change in Vhalf versus luteolin concentration (Fig. 4D),
and time constant of tail current deactivation versus luteolin
concentration (not shown) were fit with the Hill equation. Luteolin
binds to EAG1 with an EC50 of 8 mMa n daH i l lc o e f f i c i e n to f4 ,
reflecting the binding of multiple flavonoids. At concentrations up to
30 mM, the effect of luteolin was almost completely reversible
(Fig. 4A). Similar to luteolin, myricetin shifted the conductance/
voltage relationship to facilitate channel opening at more hyperpo-
larized potentials (Fig. S2B), and slowed deactivation (Fig. S2C). At
higher concentrations, both flavonoids blocked the current.
Luteolin and myricetin also decreased the fluorescence intensity
of mEAG1#505-702 in a concentration dependent manner
(Fig. 5A and Fig. S3A). Both compounds had little effect on the
fluorescence of free tryptophan (Fig. 5B and Fig. S3B), indicating
that the fluorescence change is specific to the flavonoid binding to
mEAG1#505-702. To determine the biding affinity, we plotted
the change in the peak fluorescence intensity versus the total
concentration of luteolin (Fig. 5C) and myricetin (Fig. S3C). A fit
to equation 5 (METHODS) indicated a binding affinity of
$100 mM for both luteolin and myricetin. Both luteolin and
myricetin have limited solubility in aqueous solutions and
precipitate at concentrations higher than 100 mM. In addition,
application of luteolin at concentrations higher than 100 mM and
myricetin at concentrations higher than 30 mM irreversibly
abolished currents, precluding a more in-depth characterization
of these channel regulators with fluorescence or electrophysiology
at higher concentrations.
The apparent binding affinity of the two flavonoids determined
with electrophysiology is higher than the lower limit for the
apparent binding affinity determined based on the changes in the
fluorescence. This might indicate that the effects of flavonoids on
channel gating and fluorescence originate from different binding
sites/mechanisms. Alternatively, it could reflect a difference
between binding to intact EAG1 channels and isolated C-terminal
fragments. Conformational changes of the intact channel following
ligand binding shape the apparent binding affinity determined
with electrophysiology [20], therefore, the binding affinity of an
isolated region might differ from that of the intact channel.
Further, the apparent binding affinity determined with electro-
physiology reflects cooperative ligand-binding to the full length
tetrameric channel whereas the binding affinity determined with
tryptophan fluorescence reflects ligand binding to a monomeric,
isolated C-terminal domain and therefore lacks effects of
cooperative interactions. The precise binding sites of the
flavonoids remain to be determined.
5-Chloroindole modulated EAG1 channel gating but had
no specific effect on the fluorescence of mEAG1#505-
702
Similar to the flavonoids, 5-chloroindole facilitated opening of
EAG1 channels at more hyperpolarizing potentials (Fig. 6).
100 mM 5-chloroindole shifted the Vhalf of the conductance versus
voltage relationship by an average of 2865 mV, N=3 (Fig. 6B).
Application of 100 mM 5-chloroindole also slowed the deactivation
time constant from 3.660.5 ms to 6.361.2 ms, N=3 (Fig. 6C).
Application of 5-chloroindole at concentrations higher than 1 mM
abolished the currents, yet the concentration-response curve has
not saturated at this concentration (Fig. 6D). Therefore, the
apparent binding affinity of 420 mM estimated by fitting the
concentration versus response plot with a Hill equation represents
a lower limit.
Application of 5-chloroindole decreased the fluorescence of
mEAG#505-702 to the same extent as the fluorescence of free
tryptophan in solution (not shown), indicating that the effect on the
tryptophan fluorescence is due to non-specific quenching. The
absence of a specific change in tryptophan fluorescence suggests
that 5-choloroindole modulates EAG1 channels through binding
to regions other than the C-terminal domain and/or the binding
of the 5-chloroindole to the C-terminal domain is not detected by
the tryptophan fluorescence.
Benzofurans bound to the C-terminal region but did not
facilitate opening of EAG1 channels
The benzofurans 2-(6-methoxy-1-benzofuran-3-yl) acetic acid
and benzofuran-2 carboxylic acid decreased the fluorescence
Figure 3. Chemical structures of the compounds identified as
hits. (A) Structures of flavonoids luteolin and myricetin identified as
EAG1 channel regulators by both electrophysiology and tryptophan
fluorescence portions of the screen. (B) Structure of 5-chloroindole
identified as EAG1 channel regulator by electrophysiology screen. (C)
Structures of benzofurans 2-(6-methoxy-1-benzofuran-3-yl) acetic acid
and benzofuran-2 carboxylic acid identified as binding partners of EAG1
channels by the tryptophan fluorescence portion of the screen.
doi:10.1371/journal.pone.0012523.g003
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intensity of free tryptophan (Fig. 7). At 100 mM, both compounds
were fluorescent upon excitation with 280 nm and showed
fluorescence intensity several times higher than the intensity of
mEAG1#505-702. Therefore, to determine the effect of the
compounds on the fluorescence of mEAG1#505-702, the concen-
tration was decreased to 30 mM for 2-(6-methoxy-1-benzofuran-3-
yl) acetic acid and 50 mM for benzofuran-2 carboxylic acid (Fig. 7).
The benzofurans did not affect channel function, they did not
shift the conductance versus voltage relationship or slow the
deactivation time course. The observation that the benzofurans do
not facilitate channel opening suggests that binding of these
compounds to the C-terminal domain does not evoke conforma-
tional changes that regulate EAG1 channel opening.
Discussion
Here we employed the FOL library, a collection of small natural
metabolites and fragments thereof, to identify ligands for EAG1
channels with a novel, two-pronged electrophysiology and
fluorescence-based screen. This combination of two orthogonal
methods provides a label-free approach to screen ion channels
with chemical libraries. Recording currents from inside-out
patches is the most direct approach to determine functional effect
of compounds on ion channels with intracellular ligand binding
motifs. Furthermore the fluorescence arm of the screen can be
used to identify ligands of soluble proteins or fragments that
cannot be characterized functionally with electrophysiology. The
tryptophan fluorescence screen does not require development of a
fluorescent or radio-labeled ligand, has a high signal- to-noise
ratio, and could be easily automated for a high-throughput format.
Used together, the two arms of the screen overcome limitations of
each individual portion. For example, the presence of pore
blocking compounds in the FOL library pools could obscure
detection of channel regulators in the electrophysiology arm of the
screen. The fluorescence arm of the screen, however, would detect
binding partners in pools containing pore blockers. Conversely,
the binding of some FOL compounds might not evoke changes in
tryptophan fluorescence, but their functional effects might be
picked up by the electrophysiology arm of the screen.
Screening chemical libraries is an efficient way to uncover novel
ligandsand has moved to the forefrontof drug discoveryfollowing the
development of large chemical libraries and high-throughput
screening techniques [21,22,23,24,25]. There are several problems
with the currently available screening techniques that we avoid here.
For example, most high-throughput screens assay competitive
binding between a known ligand, labeled with a fluorescent or
radioactivetag,andthesmallmoleculestobescreened.Thesescreens
therefore require prior knowledge of a ligand, precluding their use for
our study. Labeling known ligands can also present complications.
The hazardous nature of radioactivity makes the radioactive screens
costly and less popular [21,26]. The non-radioactive methods require
either fluorescent-labeling or immobilization of ligand and/or
receptor. Fluorescence labeling and immobilization of ligand and/
or receptor can disturb the ligand binding affinity and receptor
integrity. Development of fluorescent ligands can also be difficult. In
order to be useful, the fluorescent ligands should have high quantum
yield, high extinction coefficient, and small size [21].
Figure 4. Luteolin modulated currents from EAG1 channels. Current traces (A) and conductance-voltage relationship (B) for EAG1 channels
recorded in the inside-out patch configuration in the absence (black), presence (red) and after washout (grey) of 30 mM luteolin. (C) The tail current
recorded at 2120 mV, following a voltage step to 250 mV, in the absence (black) and presence (red) of 30 mM luteolin, fit with single exponentials to
give time constants of 3.5 ms before, and 6.2 ms after application of luteolin. (D) Plot of the change in the Vhalf versus luteolin concentration, fit with
a Hill equation with a binding affinity of 9.1 mM, and a Hill coefficient of 4.
doi:10.1371/journal.pone.0012523.g004
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channels, presents further challenges. The multi-subunit nature of
ion channels and presence of membrane spanning domains makes
surface immobilization based assays difficult [21]. Screens
designed specifically for ion channels typically use voltage- or
calcium-sensitive fluorescent dyes or non-radioactive tracer ions
[27]. These indirect methods detect global changes that might not
be specific to the channel of interest. To overcome these difficulties
we combined a direct functional assay based on electrophysiology
with a direct binding assay based on label-free tryptophan
fluorescence.
Using the two-pronged screen, we identified several novel ligands
of EAG1 channels. Luteolin and myricetin, both flavonoids,
emerged from the screen as regulators of EAG1 channels that
facilitated channel opening and slowed deactivation. They also
decreased tryptophan fluorescence of the isolated C-terminal
region, indicating binding to this domain. Flavonoids are plant
metabolites that are acquired by mammals through dietary intake.
Both luteolin and myricetin are present in fruits and vegetables
consumed by humans, including grapes, berries, green peppers, and
olive oil. Compounds in the flavonoid family have been previously
shown to inhibit currents from another EAG family channel,
hERG1 [28,29,30,31]. For the flavonoid hesperetin, this inhibition
has an EC50 of 267 mM, and was mediated by binding to a site in
the hERG1 channel pore [30]. It should be noted, however, that
myricetin did not inhibit hERG1 channels, and luteolin was not
examined [31]. The isoflavonoid genistein facilitated opening of
HCN1 and HCN2 channels, and this facilitation of channel
opening persisted in HCN1 channels lacking only their CNBD, but
not in channels missing the entire carboxy-terminal domain
including the C-linker [32]. While the goal of our study was to
develop a novel screen to identify ligands of EAG1 channels, future
investigationis necessary to determine whether the bindingdetected
by the fluorescence portion of the screen is responsible for the
functional effects of the flavonoids revealed by electrophysiology.
In addition to the flavonoids, 5-chloroindole was shown to
facilitate EAG1 channel opening. Whereas 5-chloroindole is not a
natural compound, it is a derivative of tryptophan and a structural
mimic of serotonin. The compound did not evoke changes in the
fluorescence of the isolated CNBD domain, suggesting that either
the binding of the compound was not detected by the fluorescence
assay and/or the indole regulates EAG1 channels through regions
other than the CNBD. One of the potential regions of action could
be the amino-terminal domain of EAG family channels that
contains a PAS domain known to serve as a ligand binding domain
in other proteins [14]. Application of both flavonoids and 5-
chloroindole at high concentrations abolished the currents,
suggesting that these compounds may be acting on site(s) in the
channel other than the intracellular domains or/and are affecting
channel behavior through a non-specific site(s) in the cell
membrane. Finally, benzofurans, metabolites synthesized in plants
but absent in human diet, were shown to bind to the carboxy-
terminal region of EAG1 channel. They did not facilitate currents
from EAG1 channels similar to the reports of the absence of
hERG1 channel facilitation by other compounds from the
benzofuran family [33,34,35].
Flavonoids, benzofurans, and indoles are abundant in nature
and have a wide range of physiological functions, including
antioxidative protection, anti-tumor and anti-inflammatory activ-
ity, and regulation of blood pressure and neurotransmitter release
[36,37,38]. The discovery of ligands from diverse chemical
families might be useful for development of new EAG1 specific
pharmaceutical agents. These ligands could be used as prototypes
of EAG1 specific drugs. Knowledge of the ligands also opens up
Figure 5. Luteolin reduced mEAG1#505-702 fluorescence in a
concentration dependent manner. (A) The inner filter corrected,
and background subtracted emission spectra of mEAG1#505-702
recorded without and with the indicated concentrations of luteolin.
(B) The inner filter corrected, and background subtracted emission
spectra of free tryptophan in solution recorded without and with the
indicated concentrations of luteolin. (C) Plots of change in the peak
emission fluorescence intensity versus total luteolin concentration for
mEAG#505-702 (filled squares) and free tryptophan (open squares), fit
with equation (5). The peak fluorescence intensity corresponded to
fluorescence intensity at 338 nm for mEAG1#505-702 and at 357 nm
for free tryptophan. The change in the peak fluorescence intensity was
calculated by subtracting averaged peak emission intensity for low
concentrations of luteolin (intensities at 0, 0.01 and 0.1 mM luteolin at
338 nm) from the peak emission intensities. The binding affinity of
luteolin was $100 mM for mEAG1#505-702.
doi:10.1371/journal.pone.0012523.g005
Identifying EAG1 Regulators
PLoS ONE | www.plosone.org 7 September 2010 | Volume 5 | Issue 9 | e12523new possibilities for in-depth study of the regulatory mechanisms
of EAG1 channels.
Materials and Methods
Preparation of the pools of FOL compounds
The FOL library was assembled from small biological
metabolites or derivatives thereof, and molecules with surface
features and solubility properties of cellular metabolites. The
selected 768 small molecules (the latest version of the FOL library
contains over 1400 compounds) were chosen from evolutionary
diverse organisms and had molecular weight of less than 350 as
previously described [18]. The FOL compounds were distributed
into a 96 well plate with each well containing 7–10 individual
compounds of dissimilar shape and dissolved in 20 ml of methanol
at a concentration of 6 mM. To prevent possible damage to
Figure 6. 5-Chloroindole modulated currents from EAG1 channels. Current traces (A) and conductance-voltage relationship (B) for EAG1
channels recorded in the inside-out patch configuration in the absence (black), presence (red) and after washout (grey) of 100 mM 5-chloroindole. (C)
The tail current at 2120 mV, following a voltage step to 250 mV, in the absence (black) and presence (red) of 100 mM 5-chloroindole, and fit with
single exponentials to give time constants of 3.0 ms before, and 4.1 ms after application of 5-chloroindole. (D) Plot of the change in the Vhalf versus 5-
chloroindole concentration, fit with a Hill equation. The binding affinity and Hill coefficient of 5-chloroindole were 420 mM and 1.4 respectively.
doi:10.1371/journal.pone.0012523.g006
Figure 7. 2-(6-methoxy-1-benzofuran-3-yl) acetic acid and benzofuran-2 carboxylic acid reduced fluorescence of mEAG1#505-702.
The inner filter corrected, and background subtracted emission spectra of mEAG1#505-702 recorded without (black) and with (red) 30 mM 2-(6-
methoxy-1-benzofuran-3-yl) acetic acid (A), and 50 mM benzofuran-2 carboxylic acid (B). Also shown are the inner filter corrected, and background
subtracted emission spectra of free tryptophan recorded without (grey) and with (green) 30 mM 2-(6-methoxy-1-benzofuran-3-yl) acetic acid (A) and
50 mM benzofuran-2 carboxylic acid (B).
doi:10.1371/journal.pone.0012523.g007
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20 minutes following centrifugation of the 96 well plates at
10006rpm for 20 minutes. After visual inspection indicated that
all methanol had evaporated, pools were re-suspended in 20 mlo f
DMSO, transferred to conical screw-cap tubes and stored at
220uC.
Electrophysiology
The cDNA encoding mEAG1 channels in pGH19 vector was
kindly provided by G. Robertson (University of Wisconsin-
Madison, Madison, WI). The cRNA was transcribed using the
T7 mMessage mMachine kit (Ambion). Xenopus laevis oocytes were
defolliculated and injected with the cRNA as previously described
[39]. Following manual removal of the vitelline membrane,
currents were recorded in the inside-out patch configuration
[40] with an EPC-10 patch-clamp amplifier (HEKA Electronik).
Data were acquired with Pulse software (HEKA Elektronik) and
analyzed with Igor (WaveMetrics, Inc). Patch pipettes were pulled
from borosilicate glass and had resistances of 0.40–1 MV after fire
polishing. The intracellular (bath) and extracellular (pipette)
solutions contained 130 mM KCl, 10 mM HEPES, 0.2 mM
EDTA, pH 7.2. The pools of individual FOL compounds were
added to the bath solution as indicated. After channel regulators
were identified, they were applied to patches with the RSC-100
solution changer (BioLogic). The mEAG1 currents were elicited by
applying a series of 0.1 s voltage pulses (ranging from 2140 to
+50 mV in 10 mV increments) from a holding potential of
2100 mV, followed by a 0.5 s voltage pulse to 2120 mV.
Currents were not leak subtracted.
To obtain conductance versus voltage curves for all electro-
physiology experiments, peak tail current amplitudes at
2120 mV, were normalized to the largest peak conductance
amplitude, which followed a step to +50 mV. These normalized
data were then plotted against the test voltage, and were fit with a
Boltzmann equation:
G
Gmax
~
1
1ze
V{Vhalf
s
   ð1Þ
Where V represents the test voltage (mV), Vhalf is the midpoint
activation voltage (mV), and s is the slope of the relation (mV).
The dose response relationships for both A ¨Vhalf and the
deactivation time constants were fit with a Hill equation:
Yx ðÞ ~Y0z
Y?zY0
1z
EC50
x
   n ð2Þ
Where Y0 represents the minimum response and Y‘ the
maximum, EC50 represents the binding affinity, and n the Hill
coefficient.
Application of FOL library to inside-out patches
In the first round of screening the pools of FOL compounds
were applied at 50 mM concentration to inside-out patches
expressing mEAG1 channels. Each of the 96 pools was applied
to three separate patches and each patch was treated with only one
pool. Changes in the current amplitude, kinetics, and voltage
dependence were used to discern the modulators of channel
activity. Once the ‘hit’ pools were identified, they were further
studied by applying the individual components to inside-out
patches at a 100 mM concentration. Similar to the application of
the FOL pools, the individual compounds were applied to three
separate patches with each patch treated with only one compound.
Due to the limited supply of the FOL library pools, we used RC-
28 chamber (Warner Instruments) optimized for small volumes.
To avoid contamination between different pools, the chamber was
thoroughly cleaned after each application with a 40 mM Na3PO4
solution, then rinsed with 1% HCl, and the bottom cover-slip was
replaced. To further avoid cross pool contamination, all tubing
and syringes were exposed to only one pool or individual
compound.
Protein expression and purification
The C-terminal region of the mEAG1 channel containing the
CNBD (mEAG1#505-702) was expressed in BL21 (DE3) cells as
described in Brelidze et al. (2009). Briefly, the DNA encoding
mEAG1#505-702 was subcloned into the pETGQ vector [41]
and transformed into BL21 (DE3) cells. The cells were grown at
37uC to the OD of 0.6–0.8 and induced subsequently with 1 M
IPTG. After growing overnight at 18uC, the cells were harvested
by centrifugation at 50006rpm for 15 min at 4uC. The cell pellet
was frozen at 280uC until further use. To purify mEAG1#505-
702, the frozen cell pellet was resuspended in a lysis buffer
(150 mM KCl, 10% Glycerol, 1 mM TCEP, 30 mM HEPES,
1 mM PMSF and 2.5 mg/ml DNase; pH 7.5) and lysed in an
Emulsiflex - C5 (Avestin). Insoluble protein was separated by
centrifugation for 45 min at 40,0006rpm at 4uC in a Beckman
45Ti rotor. The mEAG1#505-702 was then purified from the
supernatant by Ni
2+ - NTA chromatography and eluted on a
linear gradient to 500 mM imidazole. The 66His tag was cleaved
with thrombin protease (Calbiochem) and separated with size
exclusion chromatography on a Superdex 200 column (Amersham
Biosciences) equilibrated with the buffer used for the subsequent
experiments (150 mM KCl, 10% Glycerol, 1 mM TCEP, 30 mM
HEPES; pH 7.5). The purified protein was stored at 280uCi n
small aliquots and thawed immediately before the experiments.
Protein concentration was determined by absorbance at 280 nm,
and used at a concentration of 4 mM.
Fluorescence measurements
Fluorescence intensity was recorded with Fluorolog 3 spectro-
photometer (HORIBA, Jobin Yvon) using FluorEssence software.
The sample was placed in a 100 mM chamber of a quartz cuvette,
excited at 280 nm, and the emission spectrum was recorded from
300 to 500 nm. In the first round of screening the pools of the
FOL compounds were applied at 100 mM concentration to 4 mM
mEAG1#505-702 and 4 mM free tryptophan in solution. To
account for the decrease in excitation and emission intensities due
to the optical density, observed fluorescence intensities of the
sample were corrected for the inner filter effect according to the
equation [19]:
Fci~Foi   10
0:1 OD280z0:5 ODi ðÞ ð3Þ
Where Fci and Foi represent the corrected and observed
fluorescence intensities at i nm wavelength, and OD280 and ODi
are the absorbance recorded at 280 nm and i nm wavelength
respectively. To calculate the final fluorescence intensity in the
presence of an FOL compound, the corrected intensity of the FOL
compound alone was subtracted from the corrected sample
intensity. Each experiment was repeated at least three times.
Optical density of 4 mM mEAG1#505-702 at 280 nm is relatively
low. Thus, to simplify the analysis in the first round of the screen,
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the FOL compounds. Once the ligands were identified, the
fluorescence intensities used to estimate their binding affinity were
corrected for the inner filter effect due to the optical density of
both the FOL compound and mEAG1#505-702.
To estimate the binding affinity, plots of the change of the peak
fluorescence intensities versus total FOL compound concentration
were analyzed as in Brelidze et al. (2009) and Cukkemane et al.
(2007).
RL~
1
2
RtzLtzKd ðÞ {
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
4
{Rt{Lt{Kd ðÞ
2{Rt   Lt
r
ð4Þ
DF~RL   x ð5Þ
Where R, L, and RL are concentrations of the free receptor and
ligand, and receptor-ligand complex, respectively; Rt and Lt are
total receptor and ligand concentrations; Kd is the ligand binding
affinity; DF is the peak fluorescence change, and x is a scaling
factor.
The data analysis and fitting of the plots was performed in
Origin (Microcal Software, Inc). The error bars on the figures
correspond to the SEM.
Supporting Information
Figure S1 Example of data analysis for the tryptophan
fluorescence portion of the screen. (A) In each experiment,
emission spectra of mEAG1#505-702 were recorded in the
absence (black line), and presence (red line) of a FOL pool. In
parallel, the fluorescence spectra of free tryptophan were recorded
in the absence (grey trace) and presence (green trace) of the FOL
pool. Emission spectra of the FOL pool alone was recorded (blue
line) and subsequently subtracted from the spectra of
mEAG1#505-702 and free tryptophan recorded in the presence
of the pool, to correct for the background fluorescence. (B) The
absorbance spectrum of the FOL pool was recorded to correct for
the inner filter effect. (C) The inner filter corrected, and
background subtracted emission spectra of mEAG1#505-702 in
the absence (black line) and presence (red line) of the FOL pool,
and similarly analyzed free tryptophan emission spectra in the
absence (grey line) and presence (green line) of the FOL pool.
Found at: doi:10.1371/journal.pone.0012523.s001 (0.37 MB
PDF)
Figure S2 Myricetin modulated currents from EAG1 channels.
Current traces (A) and conductance/voltage relationship (B) for
EAG1 channels recorded in the inside-out patch configuration in
the absence (black) and presence (red) of 10 or 100 mM myricetin,
as indicated. (C) The tail current recorded at 2120 mV, following
a voltage step to 250 mV, in the absence (black) and presence
(red) of 100 mM myricetin, fit with single exponentials to give time
constants of 3.7 ms before, and 7.2 ms after application of
myricetin.
Found at: doi:10.1371/journal.pone.0012523.s002 (0.83 MB
PDF)
Figure S3 Myricetin reduced mEAG1#505-702 fluorescence in
a concentration dependent manner. (A) The inner filter corrected,
and background subtracted emission spectra of mEAG1#505-702
recorded without and with the indicated concentrations of
myricetin. (B) The inner filter corrected, and background
subtracted emission spectra of free tryptophan in solution recorded
without and with the indicated concentrations of myricetin. (C)
Plots of change in the peak emission fluorescence intensity versus
total myricetin concentration for mEAG#505-702 (filled squares)
and free tryptophan (open squares), fit with equation (5). The peak
fluorescence intensity corresponded to fluorescence intensity at
338 nm for mEAG1#505-702 and at 357 nm for free tryptophan.
The change in the peak fluorescence intensity was calculated by
subtracting averaged peak emission intensity for low concentra-
tions of luteolin (intensities at 0, 1 and 3 mM myricetin at 338 nm)
from the peak emission intensities. The binding affinity of
myricetin is .100 mM for mEAG1#505-702.
Found at: doi:10.1371/journal.pone.0012523.s003 (0.40 MB
PDF)
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